EUVIMEDEUVIMED entdecken
Crossref

Brusatol suppresses malignant progression of glioma via modulating the miR-574–5p/USP10/PLK1 axis

Binbin Ma, Lei Wang, Jian Li, Borui Zhang, Yichuan Wang, Na Li, Dachuan Shen, Chuanchun Han

Phytomedicine · 2025

DOI: 10.1016/j.phymed.2025.157142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Binbin Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116044, China. Electronic address: mabinbin_dmu@126.com. Hauptthemen laut MEDLINE: MicroRNAs, Proto-Oncogene Proteins, Glioma, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Natural Science Foundation of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Brusatol (BRU), a compound derived from Brucea javanica, has demonstrated notable antitumour activity across various cancer types. However, its precise mechanisms and functional roles in glioma remain incompletely understood. PURPOSE: To explore the role and downstream target of Brusatol in glioma and uncover the potential molecular mechanism. STUDY DESIGN: In vitro and in vivo experiments using glioma cell lines, as well as quantitative proteomics were performed to explore the role and downstream target of Brusatol. METHODS: Cell growth and apoptosis were investigated by colony formation and propidium iodide (PI) staining assays, respectively. Quantitative proteomics was performed to identify altered proteins in glioma cells upon treatment with different concentrations of Brusatol. The effects of ubiquitin-specific peptidase 10 (USP10) on polo-like kinase 1 (PLK1) expression were investigated by western blotting and co-immunoprecipitation (Co-IP) assays. The relationship between USP10 and miRNA-574-5p was assessed by luciferase assay and western blotting. RESULTS: In this study, we observed that Brusatol inhibited glioma cell proliferation and migration and promoted apoptosis in vitro, as well as suppressed tumour formation in vivo. Mechanistic investigations revealed that Brusatol markedly downregulated the expression of PLK1. Notably, elevated PLK1 levels attenuated the antitumour efficacy of Brusatol in LN229 and U251 cells. Furthermore, our results indicated that USP10 interacted with PLK1, suppressing its degradation and thereby counteracting the antitumour effects of Brusatol. Additionally, our data also demonstrated that miR-574-5p is significantly upregulated upon Brusatol treatment. Elevated miR-574-5p reduced USP10 expression, enhancing the inhibitory effects of Brusatol on glioma cells. CONCLUSION: Collectively, these findings indicate that the miR-574-5p/USP10/PLK1 axis plays a pivotal role in mediating the antitumour effects of Brusatol and may have potential clinical implications for glioma therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsProto-Oncogene ProteinsGliomaProtein Serine-Threonine KinasesCell Cycle ProteinsUbiquitin ThiolesteraseQuassinsAntineoplastic Agents, PhytogenicBrain NeoplasmsPolo-Like Kinase 1HumansCell Line, TumorAnimalsCell ProliferationApoptosisMice, NudeCell MovementMiceXenograft Model Antitumor AssaysMice, Inbred BALB C

Stichwörter der Autor:innen

BrusatolGliomaPLK1USP10

Substanzen

MicroRNAsPolo-Like Kinase 1Proto-Oncogene ProteinsProtein Serine-Threonine KinasesCell Cycle ProteinsUbiquitin ThiolesteraseQuassinsbrusatolAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • The Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116044, China. Electronic address: mabinbin_dmu@126.com.
  • Institute of Cancer Stem Cells, Dalian Medical University, Dalian, Liaoning 116044, China.
  • The Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116044, China.
  • National-Local Joint Engineering Research Center for Drug-Research and Development (R&D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China. Electronic address: lina0322@dmu.edu.cn.
  • Department of Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China. Electronic address: shendachuan@dlu.edu.cn.
  • Institute of Cancer Stem Cells, Dalian Medical University, Dalian, Liaoning 116044, China. Electronic address: hanzc@dmu.edu.cn.

Förderung

  • Natural Science Foundation of Liaoning Province

Zitieren

APA

Ma, B., Wang, L., Li, J., Zhang, B., Wang, Y., Li, N., Shen, D., & Han, C. (2025). Brusatol suppresses malignant progression of glioma via modulating the miR-574–5p/USP10/PLK1 axis. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157142

Vancouver

Ma B, Wang L, Li J, Zhang B, Wang Y, Li N, et al. Brusatol suppresses malignant progression of glioma via modulating the miR-574–5p/USP10/PLK1 axis. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157142

BibTeX
@article{Ma2025,
  author = {Ma, Binbin and Wang, Lei and Li, Jian and Zhang, Borui and Wang, Yichuan and Li, Na and Shen, Dachuan and Han, Chuanchun},
  title = {Brusatol suppresses malignant progression of glioma via modulating the miR-574–5p/USP10/PLK1 axis},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2025.157142}
}
Kostenlos starten →